Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Uthr - The Untold Story

Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Zoetis has underperformed the healthcare sector over the past year, and analysts remain moderately optimistic about the stock’s outlook.

Barchart

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Is Zoetis Stock Underperforming the Nasdaq?

While Zoetis has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Is United Therapeutics Stock Rallying On Tuesday?

United Therapeutics Corporation (NASDAQ:UTHR) released data on Tuesday from its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution for idiopathic pulmonary fibrosis (IPF).

Benzinga

United Therapeutics Stock Slides On Q2 Earnings: The Details

United Therapeutics Corp (NASDAQ:UTHR) reported second-quarter financial results before the market open on Wednesday. Here’s a rundown of the report.

Benzinga

3 Niche Biotech Stocks Redefining Innovation

The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR technology, and rare disease treatments driving strong demand and growth. Therefore, investing in strong biotech stocks like Halozyme Therapeutics (HALO), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR) could be wise. Read on.

StockNews.com

3 Value Stocks to Buy with P/E Ratios Below 15

Stocks with low P/E ratios can offer great returns as the market catches on to their true potential. In this article, we discuss three undervalued picks Kroger (KR), Textron (TXT), and United Therapeutics (UTHR), with P/E ratios below 15. Keep reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Undervalued Biotech Stocks Ready for a Breakout

The biotech industry's future appears bright due to advancements in biochemical and pharma technologies, AI integration, rising targeted treatments, and increased R&D spending driving breakthroughs. Therefore, it could be wise to invest in undervalued biotech stocks such as Harmony Biosciences Holdings (HRMY), United Therapeutics (UTHR), and BioMarin Pharmaceutical (BMRN). Read…

StockNews.com

3 High-Risk, High-Reward Biotech Stocks

With ever-expanding operations, rapid technological innovation, and adoption of AI, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying high risk, but rewarding biotech stocks United Therapeutics (UTHR), Entrada Therapeutics (TRDA), and Exelixis (EXEL). Continue reading.

StockNews.com

3 Biotech Stocks With Potential Breakthroughs Emerging

The biotech industry's future is promising, driven by advanced technologies like AI and VR, the rising popularity of personalized treatments, and increased R&D spending. Let's analyze the investment prospects of biotech stocks Amgen (AMGN), United Therapeutics (UTHR), and Gilead Sciences (GILD) as potential breakthroughs emerge. Read more.

StockNews.com

3 Biotech Stocks to Consider Buying Right Away

The biotechnology industry is thriving, fueled by solid government support, rising healthcare spending worldwide, gene editing breakthroughs, and rapid AI adoption. Hence, fundamentally solid biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and SIGA Technologies (SIGA) could be ideal buys for potential gains. Keep reading….

StockNews.com

3 Promising Biotech Stocks Driving Weekly Gains

The biotech industry’s prospects appear promising due to government support, regulatory changes, innovative therapies, and a focus on personalized medicine. Therefore, investors could consider buying fundamentally strong biotech stocks such as United Therapeutics (UTHR), TRACON Pharmaceuticals (TCON), and Corcept Therapeutics (CORT). Read more.

StockNews.com

3 Biotech Stocks to Jumpstart Your Portfolio Gains

The biotech industry is poised for robust growth due to increasing demand for personalized treatments, rising prevalence of chronic diseases, heightened investments in R&D, and advancements in technology. Therefore, investors could consider buying fundamentally strong biotech stocks Innoviva (INVA), ANI Pharmaceuticals (ANIP), and United Therapeutics (UTHR). Read more.

StockNews.com

Bank on the Future Returns With These 3 Biotech Stocks

With advances in gene therapy and personalized medicine, growing applications in agriculture and industrial processes, government support, and convergence of technologies, the biotechnology industry holds solid growth potential. Thus, biotech stocks United Therapeutics (UTHR), Puma Biotechnology (PBYI), and Genmab (GMAB) could be ideal investments for future returns. Read more….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Are These 4 Biotech Stocks Worth Buying in 2024?

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

StockNews.com

Top 3 Biotech Stocks for Weekly End-of-Year Profits

In the ever-evolving realm of biotechnology, technological advancements and breakthroughs are propelling significant growth. Hence, fundamentally strong biotech stocks Equillium (EQ), United Therapeutics (UTHR), and Vertex Pharmaceuticals (VRTX) might be solid investments for weekly year-end gains. Read more….

StockNews.com

4 Promising Biotech Stocks for Smart Investment Strategies

The biotechnology industry is flourishing due to the recent strides in drug formulation, technological advancements, and unwavering government support. Given this backdrop, promising biotech stocks United Therapeutics (UTHR), Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD) present smart investment options to garner significant returns. Read on….

StockNews.com

How to Enhance Your Own Strategies with POWR Ratings

Wall Street is never lacking in strategy or trading ideas. In investing, if you can combine two or more strategies that align around a particular investing idea, you can enhance your likelihood of success. This idea combines our POWR Ratings with a strategy that is currently making the rounds on…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Biotech Stocks Showing Promising Returns for October

Technological advancements and the growing investment in developing healthcare infrastructures are expected to boost the biotech industry. Therefore, it could be wise to buy fundamentally strong biotech stocks Halozyme Therapeutics (HALO), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR). Read more.

StockNews.com

3 Biotech Gainers to Consider

Robust demand, technological advancements, government and private investment, are fueling the biotech industry’s expansion and driving game-changing therapies and product development. With the industry anticipated to thrive, fundamentally strong biotech stocks Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and United Therapeutics (UTHR) look poised for substantial gains. Keep reading.

StockNews.com

Unlocking Biotech's Potential With 3 Stocks to Buy

The biotech industry’s growth is propelled by strong demand for medical support and interventions, favorable government initiatives, and rapid adoption of emerging technologies. Given the industry’s tailwinds, quality biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and Corcept Therapeutics (CORT) could be ideal buys now. Read on….

StockNews.com

3 Biotech Stocks to Buy for August

The biotechnology sector has experienced extraordinary expansion, largely due to technological advancements that continue to position the industry as a pioneering influencer in crucial areas of healthcare, agriculture, and environmental stability. Given this backdrop, quality biotech stocks Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and United Therapeutics (UTHR) could be solid…

StockNews.com

3 Biotech Stocks With 'A' POWR Ratings

The biotech industry is poised for significant growth due to the rising orphan drug formulations and the adoption of emerging technologies. Therefore, fundamentally strong biotech stocks Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and United Therapeutics (UTHR) might be solid buys. These stocks are A (Strong Buy) rated in our proprietary…

StockNews.com

4 Best Biotech Stocks According to POWR Ratings

Rapid advancements and soaring demand make the biotech sector well-positioned to witness significant growth in the foreseeable future. Given this backdrop, quality biotech stocks Amgen Inc. (AMGN), Regeneron Pharmaceuticals (REGN), United Therapeutics (UTHR), and Vanda Pharmaceuticals (VNDA) with “Strong Buy” ratings could be wise portfolio additions now. Read on….

StockNews.com

3 Biotech Stocks to Buy in 2023 That Could Help Set You up for Life

The biotech industry is well-positioned to witness significant growth on the backs of soaring demands and government spending. Moreover, given the sector’s defensive nature, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and United Therapeutics Corp. (UTHR) might be solid buys in 2023 that could help you set for life.…

1 2

People

Sristi Suman JayaswalThe

216 stories

Steven AdamsAfter

40 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.